Skip to Content

Invesco Nasdaq Biotechnology ETF IBBQ

Medalist Rating as of | See Invesco Investment Hub

Morningstar’s Analysis IBBQ

Will IBBQ outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Invesco Nasdaq Biotechnology ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBBQ

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 52.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Amgen Inc

9.27 3.0 Mil
Healthcare

Vertex Pharmaceuticals Inc

8.55 2.8 Mil
Healthcare

Regeneron Pharmaceuticals Inc

8.25 2.7 Mil
Healthcare

Gilead Sciences Inc

7.60 2.5 Mil
Healthcare

Moderna Inc

5.55 1.8 Mil
Healthcare

AstraZeneca PLC ADR

4.63 1.5 Mil
Healthcare

Biogen Inc

3.47 1.1 Mil
Healthcare

Alnylam Pharmaceuticals Inc

1.95 640,774
Healthcare

Illumina Inc

1.78 584,000
Healthcare

Biomarin Pharmaceutical Inc

1.50 492,272
Healthcare